mirtazapine has been researched along with MS (Multiple Sclerosis) in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Quiñones-Aguilar, S | 1 |
Sauri-Suárez, S | 1 |
Alcaraz-Estrada, SL | 1 |
García, S | 1 |
McGuire, JL | 1 |
Fridman, V | 1 |
Wüthrich, C | 1 |
Koralnik, IJ | 1 |
Jacobs, D | 1 |
2 other studies available for mirtazapine and MS (Multiple Sclerosis)
Article | Year |
---|---|
Progressive Multifocal Leukoencephalopathy associated to treatment with natalizumab in Mexican patient Multiple Sclerosis. Case report, analysis and update.
Topics: Female; Humans; Immunoglobulins; Leukoencephalopathy, Progressive Multifocal; Methylprednisolone; Me | 2019 |
Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS.
Topics: Aged; Brain; CD8-Positive T-Lymphocytes; Female; Humans; JC Virus; Leukoencephalopathy, Progressive | 2011 |